Pharmacogenetics of inhaled long‐acting beta2‐agonists in asthma: A systematic review
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Allergy and Immunology"
DOI: 10.1111/pai.12956
Abstract: Long‐acting beta2‐agonists (LABA) are recommended in asthma therapy; however, not all asthma patients respond well to LABA. We performed a systematic review on genetic variants associated with LABA response in patients with asthma. read more here.
Keywords: beta2 agonists; systematic review; acting beta2; long acting ... See more keywords
Genome‐wide association studies of exacerbations in children using long‐acting beta2‐agonists
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Allergy and Immunology"
DOI: 10.1111/pai.13494
Abstract: Some children with asthma experience exacerbations despite long‐acting beta2‐agonist (LABA) treatment. While this variability is partly caused by genetic variation, no genome‐wide study until now has investigated which genetic factors associated with risk of exacerbations… read more here.
Keywords: genome wide; long acting; exacerbations children; acting beta2 ... See more keywords